• Symic Bio Announces Closing of Investment led by CIP firstwordpharma
    April 26, 2019
    SAN FRANCISCO, April 25, 2019 /PRNewswire/ -- Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced the closing of financings led by Cell Innovation Partners (CIP) ...
PharmaSources Customer Service